MEDGm vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 1, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

53 providers verified independently·Independent research·How we rank →

Short answer: MEDVi scores higher on our rubric, 5.7/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - our pick of these two →or find your match

MEDVi beats MEDGm overall, scoring 5.7/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: MEDGm is from $179/mo; MEDVi is $179 first month, then $299/mo. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at MEDGm and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDGm

#53 of 53

2.7/10

MEDGm is a telehealth company selling compounded GLP-1 injections from $179/mo and dissolvable tablets from $249/mo, with brand-name Zepbound, Wegovy and Ozempic offered as a membership plus an unpublished medication cost. The compounded prices are readable before intake and the not-FDA-approved disclosure is prominent, which is more than several better-known programs manage. The gap is verification: no clinician, no pharmacy and no accreditation is named anywhere on the site or in its terms.

Visit MEDGm

Higher Rated

MEDVi

#44 of 53

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	MEDGm	MEDVi
Why each one	Publishes its compounded prices before intake and does not claim an accreditation it cannot support. Both are low bars that a surprising number of programs fail.	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	2.7/10	5.7/10
Headline Price	from $179/mo	$179 first month, then $299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Shoppers who want a compounded GLP-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	No medical director, prescribing clinician or medical group is named anywhere	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#53	#44
Get started	Visit MEDGm	Visit MEDVi

Pros & Cons Compared

MEDGm

Pros

+Compounded prices visible on the landing page without starting an intake
+Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
+Cancel any time, with a published refund policy rather than a buried one
+Claims no accreditation it cannot support, which is rarer than it should be
+HSA/FSA accepted; free shipping stated

Cons

−No medical director, prescribing clinician or medical group is named anywhere
−No compounding pharmacy is named; the terms promise a partner list that the terms do not contain
−Brand-name Zepbound, Wegovy and Ozempic are priced as a membership plus an unpublished medication cost, so no brand total can be compared
−No lab panel is offered or required at any tier
−The homepage claims 120,000+ patients on a domain registered 2026-04-08; we could not reconcile the two
−A prepaid contracted term is non-refundable, and dispensed medication is never refundable
−No third-party rating exists that we could locate and verify

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out MEDGm with a score of 5.7/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: MEDGm is from $179/mo; MEDVi is $179 first month, then $299/mo.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both MEDGm and MEDVi start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.